caesarean surgery. Delivery by caesarean section, unspecified
Conditions
Interventions
Intervention 1: In treatment group, the end of surgery, 10 mg per kg of bolus Metoclopramide injected intravenously. Intervention 2: In control group, we injected bolus dose of Normal Saline intraveno
Treatment - Drugs
Placebo
In treatment group, the end of surgery, 10 mg per kg of bolus Metoclopramide injected intravenously.
In control group, we injected bolus dose of Normal Saline intravenously instead of Metoclopramid. (in same volume of Metoclopramide
based on milliliter) the end of surgery.
Sponsors
Vice Chancellor for Research of Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Elective cesarean surgery; patients aged 20-35 years; American Society of Anesthesiologists (ASA) class I and II. Exclusion criteria: indisposition; emergency section; prolonged surgery; smoking and narcotic user; psychiatric disorders.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: During 24 hours after the surgry, at time 2, 4, 6, 12, 18, 24. Method of measurement: visual analog scale from 0 (without pain) to 10 (extremely pain). | — |
Secondary
| Measure | Time frame |
|---|---|
| Ponv. Timepoint: During 24 hour after the surgery. Method of measurement: Visual Analog Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sara Malekshah
Mazandaran University of Medical Science
Outcome results
None listed